Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Current Leases: 2019-2024

Historic Current Leases for Protagonist Therapeutics (PTGX) over the last 6 years, with Dec 2024 value amounting to $510,000.

  • Protagonist Therapeutics' Current Leases rose 4851.11% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 4851.11%. This contributed to the annual value of $510,000 for FY2024, which is 55.30% down from last year.
  • Latest data reveals that Protagonist Therapeutics reported Current Leases of $510,000 as of FY2024, which was down 55.30% from $1.1 million recorded in FY2023.
  • Protagonist Therapeutics' 5-year Current Leases high stood at $2.5 million for FY2022, and its period low was $510,000 during FY2024.
  • Moreover, its 3-year median value for Current Leases was $1.1 million (2023), whereas its average is $1.4 million.
  • In the last 5 years, Protagonist Therapeutics' Current Leases skyrocketed by 50.79% in 2021 and then slumped by 55.30% in 2024.
  • Yearly analysis of 5 years shows Protagonist Therapeutics' Current Leases stood at $1.5 million in 2020, then soared by 50.79% to $2.2 million in 2021, then increased by 14.32% to $2.5 million in 2022, then crashed by 54.63% to $1.1 million in 2023, then crashed by 55.30% to $510,000 in 2024.